Rain Therapeutics reported for 2021 Rain Therapeutics from 3/4/22

User image

Sergey Novikov

News editor
press@blackterminal.com

Rain Therapeutics' GAAP loss for 2021 was $51.394 million, up 2.4 times from $21.083 million in the previous year.

Rain Therapeutics

Review

Source:

{source} pictogram

investors.rainthera.com

Sergey Novikov

News editor

Write your comment first

News feed

MTS-Bank's profit increased by more than 30% in the first quarter%

Yesterday at 14:12 MBNK

Bank Saint Petersburg reports for the first quarter of 2024

Yesterday at 10:03 BSPB

Shareholders of Rosbank approved dividends for 2023

Yesterday at 09:56 ROSB

Shareholders of Chelyabinsk Press-Forging Plant approved dividends for 2023

Yesterday at 09:50 CHKZ

HeadHunter can launch its own social network in the summer

Yesterday at 09:45 HHRU

Shareholders of Perm Energy Supply Company approved dividends for 2023

5/16/24 PMSB

Kamaz develops its own tourist bus

5/16/24 KMAZ

The Board of Directors of Leeuwenhoek recommended paying dividends out of the retained earnings of previous years in the amount of no more than 50 million rubles or ₽0.9445 per ordinary share. The last day of buying securities for receiving dividends is June 27, 2024. The dividend yield may be 1.59%.

5/16/24 LVHK

Rosbank reports for the first quarter of 2023

5/16/24 ROSB

Tinkoff reports for the first quarter of 2024

5/16/24 TCSG